SIREN : 450328315
ECO-MED is a French company founded 22 years ago, specialized in the sector Activités spécialisées, scientifiques et techniques diverses. Based in MARSEILLE (13006), this company of category PME shows in 2024 a revenue of 6.2 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-09
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2024 | 2023 | 2022 | 2021 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 6 228 059 € | 5 504 141 € | 4 092 028 € | 4 073 409 € | 3 706 829 € | 3 001 599 € | 3 022 210 € | 2 867 128 € |
| Net income | 1 051 810 € | 219 952 € | 350 347 € | 781 550 € | -297 121 € | 458 270 € | 397 270 € | 16 188 € |
| EBITDA | 998 437 € | 195 070 € | 86 580 € | 156 724 € | 470 445 € | -24 559 € | 36 019 € | -123 628 € |
| Net margin | 16.9% | 4.0% | 8.6% | 19.2% | -8.0% | 15.3% | 13.1% | 0.6% |
In 2024, ECO-MED achieves revenue of 6.2 M€. Over the period 2016-2024, the company shows strong growth with a CAGR (compound annual growth rate) of +10.2%. Vs 2023, growth of +13% (5.5 M€ -> 6.2 M€). After deducting consumption (0 €), gross margin stands at 6.2 M€, i.e. a rate of 100%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 998 k€, representing 16.0% of revenue. Positive scissor effect: EBITDA margin improves by +12.5 pts, sign of improved operational efficiency. This high EBITDA margin provides strong self-financing capacity and resilience to uncertainties. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 1.1 M€, i.e. 16.9% of revenue. This profit can be retained or distributed to shareholders.
6 228 059 €
6 228 059 €
998 437 €
972 924 €
1 051 810 €
16.0%
The debt ratio (= Financial debt / Equity x 100) stands at 2%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 53%. This high autonomy means the company finances most of its assets through equity, a sign of strength. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 0.1 years of cash flow to repay all financial debt. This short period demonstrates excellent debt sustainability. Cash flow represents 18.8% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment. This high level provides strong self-financing capacity.
2.247%
53.06%
18.81%
0.072
18.0%
In 2024, the debt ratio of ECO-MED (2.25) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
In 2024, the financial autonomy of ECO-MED (53.1%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
In 2024, the repayment capacity of ECO-MED (0.07) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
The liquidity ratio (= Current assets / Current liabilities) stands at 421.12. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 2.2x. Financial charges are adequately covered by operations.
421.125
2.242
In 2024, the liquidity ratio of ECO-MED (421.12) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
In 2024, the interest coverage of ECO-MED (2.2x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 183 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 39 days. The gap of 144 days means the company finances its customers for over a month before being paid relative to supplier payments. This weighs on cash flow. Overall, WCR represents 208 days of revenue, i.e. 3.6 M€ to permanently finance. Over 2016-2024, WCR increased by +233%, requiring additional financing.
3 590 414 €
183 j
39 j
0 j
208 j
Based on 98 transactions of similar company sales
(all years),
the value of ECO-MED is estimated at
3 429 556 €
(range 859 509€ - 5 701 769€).
With an EBITDA of 998 437€, the sector multiple of 3.5x is applied.
The price/revenue ratio is 0.36x
(conservative valuation).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Medium reliability: estimate to be confirmed with in-depth analysis.
Ajustez les pondérations selon votre analyse
This estimate is based on the analysis of 98 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare ECO-MED with other companies in the same sector:
Voir toutes les statistiques du secteur Activités spécialisées, scientifiques et techniques diverses
The revenue of ECO-MED in 2024 is 6.2 M€.
Yes, ECO-MED generated a net profit of 1.1 M€ in 2024.
The headquarters of ECO-MED is located in MARSEILLE (13006), in the department Bouches-du-Rhone.
The tax return of ECO-MED is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
ECO-MED operates in the sector Activités spécialisées, scientifiques et techniques diverses (NAF code 74.90B). See the 'Sector positioning' section above to compare the company with its competitors.